The molecular pathology of rosacea.
Rosacea is a common and chronic inflammatory skin disease that affects over 10 million Americans. Although the phenotypes of rosacea are clinically heterogeneous, they are all related by the presence of chronic facial skin inflammation. Until recently, the pathophysiology of this disease has been poorly understood and limited to descriptions of factors that exacerbate or improve this disorder. Recent molecular studies suggest that an altered innate immune response is involved in the pathogenesis of the vascular and inflammatory disease seen in patients with rosacea. These findings may help explain the benefits of current treatments and suggest new therapeutic strategies helpful for alleviating this disease. This article discusses the possible molecular mechanisms for the pathogenesis of rosacea from current clinical observations and laboratory research.
Yamasaki
Kenshi
K
Division of Dermatology, University of California, San Diego, CA 92161, USA. keyamasa@ucsd.edu
Gallo
Richard L
RL
D000818:Animals; D001424:Bacterial Infections / Q000150:complications; D004730:Endothelium, Vascular / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators / Q000378:metabolism*; D008924:Mite Infestations / Q000150:complications; D018384:Oxidative Stress; D010447:Peptide Hydrolases / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D012307:Risk Factors; D012393:Rosacea / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction; D012867:Skin / Q000098:blood supply / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000528:radiation effects; D014466:Ultraviolet Rays / Q000009:adverse effects
D018836:Inflammation Mediators; D017382:Reactive Oxygen Species; D010447:Peptide Hydrolases